Hutchmed Advances ORPATHYS-TAGRISSO Lung Cancer Treatment Filings in Europe, Japan

MT newswire2026/11/02 08:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:20 AM EST, 11/02/2026 (MT Newswires) -- Hutchmed (HCM) said Monday that European and Japanese regulators have accepted filings for its Orpathys combination with AstraZeneca's (AZN) Tagrisso to treat certain patients with MET-driven, EGFR-mutated non-small cell lung cancer. The company said the European Medicines Agency validated and accepted AstraZeneca's marketing authorization application. In Japan, the Ministry of Health, Labour and Welfare also accepted AstraZeneca's new drug application for review. The company said the filings are supported by results from the phase III Saffron trial, which showed the combination reduced the risk of disease progression or death by 45% and the risk of death by 32% versus chemotherapy. The combination extended median progression-free survival to 7.6 months from 5.4 months and median overall survival to 17.8 months from 12.9 months. According to Hutchmed, the treatment's safety profile was consistent with the known profiles of both medicines, with no new safety concerns.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.

华尔街见闻•2026/11/09 09:21